Advances in CAR-T Cell Therapy Across Hematologic Malignancies: From Pipeline to Clinical Practice

Download slides and view an on-demand webcast from a live symposium on best practices in using CAR T-cell therapies for leukemias lymphomas and myeloma.

Share

Program Content

Activities

CAR T: Lymphomas
CAR T-Cell Therapy for Lymphomas
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2021

Expires: December 09, 2022

CAR T: Myeloma
CAR T-Cell Therapy for Multiple Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2021

Expires: December 09, 2022

CAR T: ALL/Toxicities
CAR T-Cell Therapy for ALL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2021

Expires: December 09, 2022

<i>EP</i>: CAR T
ExpressPoints:
Advances in CAR-T Cell Therapy Across Hematologic Malignancies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 20, 2021

Expires: December 19, 2022

No activities added yet

Faculty

cover img faculity

Jesus G. Berdeja, MD

Director, Multiple Myeloma Program
Sarah Cannon Research Institute
Attending Physician
Sarah Cannon Center for Blood Cancer
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

cover img faculity

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb